Recent gene-expression profiling in BC identified PRELP among the PG genes whose decreased expression correlates with enhanced tumour aggressiveness and poorer survival, suggesting that PRELP acts as a stromal tumour-suppressive factor modulating ECM integrity and TGFβ-dependent signalling [36]. Here, PRELP is linked to breast cancer.